Postpoliomyelitis Syndrome

Postpoliomyelitis syndrome is characterized by a sudden or progressive loss of muscle strength, muscle atrophy, muscle pain, fatigue, intolerance to cold, after a period of at least 15 years from the acute polio virus infection, a period of neurological and functional stability. Here is the latest research.

July 17, 2020
Open Access

Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019

MMWR. Morbidity and Mortality Weekly Report
Grace MacklinOndrej Mach
July 17, 2020

Effects of the Interactive Videogame Nintendo Wii Sports on Upper Limb Motor Function of Individuals with Post-polio Syndrome: Randomized Clinical Trial

Games for Health Journal
Erika Christina Gouveia E SilvaJosé Eduardo Pompeu
September 17, 2020

Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV

Risk Analysis : an Official Publication of the Society for Risk Analysis
Dominika A Kalkowska, Kimberly M Thompson
July 15, 2020

Nerve transfers for acute flaccid myelitis: a case series

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
C O HeiseM G Siqueira
August 17, 2020

One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine

The Journal of Infectious Diseases
Ali Faisal SaleemAnita K M Zaidi
July 28, 2020
Review
Open Access

Enterovirus infection and acute flaccid myelitis

Current Opinion in Virology
Priyanka Uprety, Erin H Graf
September 12, 2020
Review
Open Access

Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world

The Lancet Global Health
Africa Regional Commission for the Certification of Poliomyelitis Eradication
August 10, 2020
Case Report

EVAR with aortic placement of a single JOTEC E-iliac Stent Graft System in a patient with poliomyelitis aorto-iliac deformities

Annals of Vascular Surgery
Matteo OrricoNicola Mangialard
August 23, 2020
Open Access

Characterization of the Relationship between the Chaperone and Lipid-Binding Functions of the 70-kDa Heat-Shock Protein, HspA1A

International Journal of Molecular Sciences
Larissa SmuldersNikolas Nikolaidis
September 20, 2020

National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: An analysis of 13 years of demographic surveillance data from an urban African area

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Andreas AndersenPeter Aaby
July 1, 2020

The risks of medical complacency towards poliomyelitis

The Medical Journal of Australia
Meryta MayRhonda Owen
July 9, 2020
Open Access

Universal hepatitis A vaccination in Brazil: analysis of vaccination coverage and incidence five years after program implementation

Revista brasileira de epidemiologia = Brazilian journal of epidemiology
Wagner Izidoro de Brito, Francisco José Dutra Souto
July 1, 2020
Open Access

MSH1 is required for maintenance of the low mutation rates in plant mitochondrial and plastid genomes

Proceedings of the National Academy of Sciences of the United States of America
Zhiqiang WuDaniel B Sloan
August 14, 2020

Health-related quality of life and multidimensional fitness profile in polio survivors

Disability and Rehabilitation
Narcís GusiJosué Prieto-Prieto
July 2, 2020
Preprint
Open Access

Community structure mediates Sabin 2 polio vaccine virus transmission

MedRxiv : the Preprint Server for Health Sciences
M. FamulareMami Taniuchi

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/postpoliomyelitis-syndrome/2ea118b7-7ce2-4613-a09e-d2f601a3a256